FGL-S
FGL-S is a brain-boosting peptide derived from neural cell adhesion molecules that enhances memory, learning, and neural repair by strengthening connections between brain cells. It mimics natural signals to increase neurotransmitter release, promote new synapse formation, and protect against damage from stress, toxins, or injury.
Route
Subcutaneous injection
Dose range
2 mg – 10 mg
Frequency
1–2 times per day
Cycle length
4–6 weeks
Overview
FGL-S is a brain-boosting peptide derived from neural cell adhesion molecules that enhances memory, learning, and neural repair by strengthening connections between brain cells. It mimics natural signals to increase neurotransmitter release, promote new synapse formation, and protect against damage from stress, toxins, or injury. Research shows it improves working memory, reduces inflammation in the brain, and aids recovery from conditions like ischemia or chemical-induced deficits, making it a promising tool for cognitive health.
Key clinical perks include sharper focus, better problem-solving, and resilience to brain fog or aging-related decline. It facilitates remyelination (repairing nerve insulation), enhances glutamate receptor delivery for stronger signaling, and inhibits harmful kinases linked to Alzheimer’s pathology. Users in studies report improved hippocampal function—the brain’s memory center—leading to faster learning and emotional stability. Nasal or injected forms allow easy brain access, ideal for students, professionals under stress, or those recovering from concussions. By fostering synaptic plasticity without stimulants, FGL-S supports long-term brain vitality and protection against neurodegeneration.
Studied benefits
- A small-peptide mimetic derived from Neural Cell Adhesion Molecule (NCAM)
- It promotes neuroplasticity, enhances memory formation, and provides neuroprotection against damage in the hippocampus
Reported side effects
- Research is primarily preclinical
- however, it appears well-tolerated with no significant systemic toxicity reported in animal models
Protocol
Dosing Schedule (Subcutaneous/Intranasal)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Method | Daily Dose (mg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Intranasal | 2–5 mg | 200 units (2 mL) | + Log |
| Subcutaneous | 10 mg | 400 units (4 mL) | + Log |
Frequency
1–2 times per day.
Timing
Consistent daily timing.
Cycle length
4–6 weeks.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
1 doses of 5 mg per vial
At the starting dose (5 mg × 7/week for a 4-week cycle) you would use about 140 mg, i.e. 28 × 5 mg vials. Higher phases use proportionally more.
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Focus on a diet rich in neuroprotective nutrients, such as polyphenols and healthy fats, to support the peptide's goal of enhancing synaptic plasticity and neural growth. Engage in regular aerobic exercise to increase blood flow to the brain and stimulate the release of endogenous BDNF (Brain-Derived Neurotrophic Factor). Ensure 7–9 hours of quality sleep to facilitate neural repair and the consolidation of new information or motor skills. Minimize stress and avoid neuro-inflammatory agents like sugar and trans fats, which can hinder the peptide's ability to facilitate the binding of neural cell adhesion molecules.
Evidence
Research summaries
Effect of an NCAM Mimetic Peptide FGL on Spatial Learning and Memory
Findings: Improves memory, helps the brain learn new tasks faster, and protects against chemical brain damage.
FGL is a peptide designed to copy a molecule your brain uses to stick neurons together (called NCAM). In this experiment, rats were given a chemical that messes up their memory, similar to how schizophrenia or brain fog works. When they were treated with FGL, their memory problems almost completely disappeared. They were able to learn and remember the location of a hidden platform in a water maze just as well as healthy rats. This suggests that FGL helps the brain "wire" itself better, protecting the connections used for working memory. For a student, this is like having a backup generator that keeps the lights on even when there's a storm, ensuring you can still study and remember things clearly.
Read the study ↗FGL Peptide Attenuates Neuronal Death and Promotes Survival
Findings: Stops brain cells from dying after injury (like a stroke) and encourages nerves to grow.
When the brain gets injured, like from a lack of oxygen or a hard hit, cells start to die off. FGL acts as a "survival signal." It binds to a specific receptor (FGFR) on the surface of brain cells and tells them, "Don't die, grow!" In lab tests, neurons treated with FGL were much more likely to survive stressful conditions. It also stimulated "neurite outgrowth," which means it helped the nerve cells sprout new branches to connect to their neighbors. This is crucial for recovering from brain injuries or diseases like Alzheimer's, where losing connections leads to memory loss. It’s essentially fertilizer for your brain cells.
Read the study ↗More references (6)
- FGL-induced anti-inflammatory effects and CD200, 2013
- A neural cell adhesion molecule-derived peptide (FGL) in AD models, 2011
- Neuroprotective effects of FGL in vivo, 2008
- NCAM-derived peptide FGL reduces cognitive impairment, 2007
- FGL increases neurite outgrowth and promotes neuronal survival, 2006
- Isolation of Fibroblast Growth Loop (FGL) peptide, 2004
Identification
Chemistry
- cas
- Not established for FGL-S; EU patent EP2225272B1 covers NCAM-derived FGL peptides
- formula
- C₁₀₀H₁₅₇N₂₇O₃₄ (estimated for 15-amino acid FGL peptide; variant formulations may differ)
- molecular weight
- Approximately 2,250 g/mol (for full 15-amino acid FGL); shorter analogs may vary
- sequence
- Core FGL-derived from NCAM's second fibronectin type III repeat (FNIII-2 module); full length typically 15 amino acids; exact sequence proprietary to developers
- source
- Synthetic; rationally designed based on the fibronectin type III domain (particularly FN II module) of naturally occurring NCAM
- biosynthesis
- Non-ribosomal; chemically synthesized peptide
- type
- Linear peptide; derived from specific functional domain of larger NCAM protein
Keep exploring
Related peptides
Adamax
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks
Cortagen
- Route
- Subcutaneous
- Dose
- 1 mg – 2 mg
- Cycle
- 4 weeks
Dihexa
- Route
- Topical
- Dose
- 5 mg – 20 mg
- Cycle
- 4–8 weeks